Omixon Collaborates with G3 and Genomics England to Validate HLA Genotyping from WGS Data
Omixon has announced a collaboration with the Global Genomics Group (G3) to validate its Target HLA™ software to determine HLA genotypes from whole genome datasets. G3 is providing the whole genome datasets and the corresponding DNA samples of 340 subjects enrolled in the clinical trial called Genetic Loci and...